232 related articles for article (PubMed ID: 24113582)
1. Genetic correction of stem cells in the treatment of inherited diseases and focus on xeroderma pigmentosum.
Rouanet S; Warrick E; Gache Y; Scarzello S; Avril MF; Bernerd F; Magnaldo T
Int J Mol Sci; 2013 Oct; 14(10):20019-36. PubMed ID: 24113582
[TBL] [Abstract][Full Text] [Related]
2. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
3. Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells.
Warrick E; Garcia M; Chagnoleau C; Chevallier O; Bergoglio V; Sartori D; Mavilio F; Angulo JF; Avril MF; Sarasin A; Larcher F; Del Rio M; Bernerd F; Magnaldo T
Mol Ther; 2012 Apr; 20(4):798-807. PubMed ID: 22068429
[TBL] [Abstract][Full Text] [Related]
4. [Epidermal stem cells and ex vivo cutaneous gene therapy: application to xeroderma pigmentosum].
Warrick E; Bergoglio V; Bernerd F; Magnaldo T
J Soc Biol; 2008; 202(1):33-41. PubMed ID: 18460307
[TBL] [Abstract][Full Text] [Related]
5. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
[TBL] [Abstract][Full Text] [Related]
6. Clues to epidermal cancer proneness revealed by reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro.
Bernerd F; Asselineau D; Vioux C; Chevallier-Lagente O; Bouadjar B; Sarasin A; Magnaldo T
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7817-22. PubMed ID: 11438733
[TBL] [Abstract][Full Text] [Related]
7. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
8. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light.
Bernerd F; Asselineau D; Frechet M; Sarasin A; Magnaldo T
Photochem Photobiol; 2005; 81(1):19-24. PubMed ID: 15369409
[TBL] [Abstract][Full Text] [Related]
9. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
[TBL] [Abstract][Full Text] [Related]
10. [Xeroderma pigmentosum].
Takeuchi S
Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
[TBL] [Abstract][Full Text] [Related]
11. Shining a light on xeroderma pigmentosum.
DiGiovanna JJ; Kraemer KH
J Invest Dermatol; 2012 Mar; 132(3 Pt 2):785-96. PubMed ID: 22217736
[TBL] [Abstract][Full Text] [Related]
12. Xeroderma pigmentosum: from genetics to hopes and realities of cutaneous gene therapy.
Magnaldo T
Expert Opin Biol Ther; 2004 Feb; 4(2):169-79. PubMed ID: 14998776
[TBL] [Abstract][Full Text] [Related]
13. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
Dupuy A; Sarasin A
Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
[TBL] [Abstract][Full Text] [Related]
14. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
[TBL] [Abstract][Full Text] [Related]
15. Complementation assays adapted for DNA repair-deficient keratinocytes.
Fréchet M; Bergoglio V; Chevallier-Lagente O; Sarasin A; Magnaldo T
Methods Mol Biol; 2006; 314():9-23. PubMed ID: 16673870
[TBL] [Abstract][Full Text] [Related]
16. Genetic reversion of inherited skin disorders.
Magnaldo T; Sarasin A
Mutat Res; 2002 Nov; 509(1-2):211-20. PubMed ID: 12427540
[TBL] [Abstract][Full Text] [Related]
17. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
18. Functional lentiviral vectors for xeroderma pigmentosum gene therapy.
Marchetto MC; Correa RG; Menck CF; Muotri AR
J Biotechnol; 2006 Dec; 126(4):424-30. PubMed ID: 16857285
[TBL] [Abstract][Full Text] [Related]
19. Xeroderma pigmentosum clinical practice guidelines.
Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
[TBL] [Abstract][Full Text] [Related]
20. Xeroderma pigmentosum: neck lymph node metastasis of a squamous cell carcinoma of the skin treated with cetuximab.
Rubió Casadevall J; Graña-Suárez B; Hernandez-Yagüe X; Vayreda Ribera J; Huc Grasa O; Brunet Vidal J
Eur J Dermatol; 2009; 19(2):163-5. PubMed ID: 19106040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
